Trials / Completed
CompletedNCT01013376
A Pilot Study of the Safety of MC-1101 in Both Normal Volunteers and Patients With Early Dry AMD
A Pilot, Single-Center, Open-Label Study of the Safety of MC-1101 in Both Normal Volunteers and Patients With Early Non-exudative Age-Related Macular Degeneration
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- MacuCLEAR, Inc. · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Accepted
Summary
The safety and comfort of repeated administrations of a topically-administered ophthalmic formulation of MC-1101 will be established through investigator assessments and subject reporting over a 3 day period. Safety assessments will be performed on both normal, healthy subjects as well as those with the signs and symptoms of early non-exudative age-related macular degeneration (dry AMD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MC-1101 | MC-1101 1.0% |
| DRUG | Vehicle | Vehicle |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2009-08-01
- Completion
- 2009-08-01
- First posted
- 2009-11-13
- Last updated
- 2009-11-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01013376. Inclusion in this directory is not an endorsement.